| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |